Literature DB >> 10403444

Behavioral effects of ivermectin in mice.

J A Davis1, R Paylor, M P McDonald, M Libbey, A Ligler, K Bryant, J N Crawley.   

Abstract

BACKGROUND AND
PURPOSE: Ivermectin is a common anthelmintic drug, widely used in laboratory rodents for treatment of pinworm and mite infestations. We evaluated the action of ivermectin on sensitive behavioral tasks in mice during treatment for mites within a barrier facility.
METHODS: A total of 21 (5 males, 16 females) mice (129/SvEv) were used for measuring body weight, open field locomotor activity, and rotarod motor coordination. For acoustic startle and prepulse inhibition, 20 C57BL/6J and 29 AKR/J mice were studied. For the Morris water task, the same 20 C57BL/6J mice were studied. Ivermectin (0.08% sheep drench) was administered in the drinking water of the home cage for 8 weeks. Control groups received normal tap water in identical bottles.
RESULTS: Ivermectin did not affect general health, body weight, motor coordination, swimming behavior, or spatial learning in several inbred strains of mice. However, it induced a small but significant effect on some sensitive behaviors.
CONCLUSIONS: A cautious approach to initiating ivermectin treatment in mice should be used for sensitive behavioral experiments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403444

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  17 in total

1.  Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors.

Authors:  Liana Asatryan; Maya Popova; Daya Perkins; James R Trudell; Ronald L Alkana; Daryl L Davies
Journal:  J Pharmacol Exp Ther       Date:  2010-06-11       Impact factor: 4.030

2.  Ivermectin reduces alcohol intake and preference in mice.

Authors:  Megan M Yardley; Letisha Wyatt; Sheraz Khoja; Liana Asatryan; Marcia J Ramaker; Deborah A Finn; Ronald L Alkana; Nhat Huynh; Stan G Louie; Nicos A Petasis; Marco Bortolato; Daryl L Davies
Journal:  Neuropharmacology       Date:  2012-03-23       Impact factor: 5.250

3.  Treatment and eradication of murine fur mites: I. Toxicologic evaluation of ivermectin-compounded feed.

Authors:  Rodolfo J Ricart Arbona; Neil S Lipman; Elyn R Riedel; Felix R Wolf
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-09       Impact factor: 1.232

4.  Treatment and eradication of murine fur mites: III. Treatment of a large mouse colony with ivermectin-compounded feed.

Authors:  Rodolfo J Ricart Arbona; Neil S Lipman; Felix R Wolf
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-09       Impact factor: 1.232

5.  Sex-specific effects of parasitism on survival and reproduction of a rodent host in a subtropical montane region.

Authors:  Hsuan-Yi Lo; Pei-Jen L Shaner
Journal:  Oecologia       Date:  2014-11-23       Impact factor: 3.225

6.  Use of selamectin and moxidectin in the treatment of mouse fur mites.

Authors:  Deborah M Mook; Kimberly A Benjamin
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

7.  Zika virus pathogenesis and current therapeutic advances.

Authors:  Caroline Mwaliko; Raphael Nyaruaba; Lu Zhao; Evans Atoni; Samuel Karungu; Matilu Mwau; Dimitri Lavillette; Han Xia; Zhiming Yuan
Journal:  Pathog Glob Health       Date:  2020-11-14       Impact factor: 2.894

8.  Guidance Regarding Sample Collection and Refinement of Fecal Flotation Exam for the Isolation of Aspiculuris tetraptera.

Authors:  Anna E Goodroe; Victoria K Baxter; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

9.  Role of the medial prefrontal cortex in cataplexy.

Authors:  Yo Oishi; Rhiannan H Williams; Lindsay Agostinelli; Elda Arrigoni; Patrick M Fuller; Takatoshi Mochizuki; Clifford B Saper; Thomas E Scammell
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

10.  Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin.

Authors:  Marco Bortolato; Megan M Yardley; Sheraz Khoja; Sean C Godar; Liana Asatryan; Deborah A Finn; Ronald L Alkana; Stan G Louie; Daryl L Davies
Journal:  Int J Neuropsychopharmacol       Date:  2012-09-17       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.